Delivery Order SPE2DR25D6029-SPE2DR26FXS3M
Award Date 3/2/26
Potential Completion Date 3/3/26
Potential Value $1.2K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Nalbuphine 100 mg/10 mL vials with a firm fixed price ceiling value of $1,270.82. This is a non-set-aside, competitively awarded contract with an ultimate completion date of September 23, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- <p>The Defense Logistics Agency issued a $1,230.32 delivery order to AmerisourceBergen Drug Corp on February 26, 2026, for nalbuphine 100 mg/10 ml vials.</p> <p>The order was issued under the DLA Troop Support Medical indefinite delivery contract (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999 through December 2026. Place of performance is Conshohocken, PA. The order has a firm fixed price and an ultimate completion date of February 27, 2026.</p>
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Nalbuphine 100 mg/10 mL vials with a ceiling value of $1,366.25. This firm fixed-price, non-set-aside contract is classified as a delivery order and is scheduled for completion by September 9, 2025. The products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,906.23 to AmerisourceBergen Drug Corp for the supply of Nalbuphine 100 mg/10 mL vials on April 29, 2025. This competitively awarded, firm fixed-price delivery order is classified as a non-set-aside contract and carries an ultimate completion date of April 30, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,230.32 to AmerisourceBergen Drug Corp for the supply of Nalbuphine 100 mg/10 ml vials on January 20, 2026, with completion scheduled for January 21, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,845.48 to AmerisourceBergen Drug Corp for the supply of Nalbuphine 100 mg/10 ml vials on December 2, 2025, with an ultimate completion date of December 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through...
- The Defense Logistics Agency awarded a delivery order valued at $1,373.29 to AmerisourceBergen Drug Corp for the supply of Nalbuphine 100 mg/10 mL vials. This competitively awarded, firm fixed-price delivery order was executed on December 2, 2025, with an ultimate completion date of December 3, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. Nalbuphine is an opioid analgesic used for pain management in military and...
- The Defense Logistics Agency awarded a delivery order valued at $1,688.22 to AmerisourceBergen Drug Corp for the supply of Nalbuphine 100 mg/10 mL vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 22, 2026. The product will be performed from the awardee's location in Conshohocken, Pennsylvania. Nalbuphine is a synthetic opioid analgesic used in pain management and anesthesia support, making this delivery order consistent with the Defense...
- The Defense Logistics Agency awarded a $6,055.30 delivery order to AmerisourceBergen Drug Corp on January 21, 2026, for the supply of Nalbuphine 100 mg/10 mL vials. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by January 22, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Nalbuphine is an opioid analgesic commonly used within military and federal healthcare systems for pain management...
- The Defense Logistics Agency awarded a $1,488.91 delivery order to AmerisourceBergen Drug Corp for Nalbuphine 100 mg/10 mL vials, a narcotic analgesic used for pain management. The contract, awarded June 2, 2025, with completion targeted for June 3, 2025, operates under a firm fixed price structure with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...